Chheda - Health Rising

Network Medicine for ME/CFS: Wengzhong Xiao and the Open Medicine Foundation’s Severe ME/CFS Big Data Study

Simmaron’s ME/CFS Trial of Rapamycin – a Mitochondrial Enhancer – to Begin Soon

by Cort Johnson | Nov 14, 2023 | Autophagy, Chheda, Energy Production, Homepage, Kaufman, Oxidative Stress, Peterson

Clinical trials – once a rarity for chronic fatigue syndrome (ME/CFS) – suddenly seem to be popping up all around the place. The Open Medicine Foundation just announced its first two-fer (two drugs tested together) clinical trial, Solve M.E. has funded at...

From Infectious Disease Specialist to ME/CFS Expert: Dr. Bela Chedda Talks

by Cort Johnson | Aug 26, 2019 | Chheda, Craniocervical Instability, Homepage, IVIG, Kaufman, Low Dose Naltrexone, Mast cell activation syndrome, Small Intestine Bowel - Overgrowth, Treatment, Xifaxin

Dr. Chheda’s Road to ME/CFS I met Dr. Chheda of the Center for Complex Diseases at Ron Davis’s Working Group Meetings funded by the Open Medicine Foundation. She graciously agreed to talk more about how she approaches treating ME/CFS in her practice. I was...

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

BECOME A RECURRING DONOR

GIVE A ONE-TIME DONATION

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Structural Failure

Allyn Archer

Atlanta, United States

Former occupation: Architect, Professor of Architecture

Total Economic Losses:

$2,768,291

Lives Interrupted Stats

Number of Stories: 43

Years of Work Lost: 326

Average Total Economic Losses:

$869,388

Total Economic Losses:

$26,951,026

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Network Medicine for ME/CFS: Wengzhong Xiao and the Open Medicine Foundation’s Severe ME/CFS Big Data Study

Simmaron’s ME/CFS Trial of Rapamycin – a Mitochondrial Enhancer – to Begin Soon

From Infectious Disease Specialist to ME/CFS Expert: Dr. Bela Chedda Talks

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest